SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-22-028740
Filing Date
2022-12-08
Accepted
2022-12-08 15:53:22
Documents
16
Period of Report
2022-12-07
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K govx20221207_8k.htm   iXBRL 8-K 35373
2 EXHIBIT 10.1 ex_454105.htm EX-10.1 186156
3 EXHIBIT 99.1 ex_454106.htm EX-99.1 11395
8 geovax01.jpg GRAPHIC 5424
  Complete submission text file 0001437749-22-028740.txt   433850

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA govx-20221207.xsd EX-101.SCH 4078
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE govx-20221207_def.xml EX-101.DEF 13570
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE govx-20221207_lab.xml EX-101.LAB 17787
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE govx-20221207_pre.xml EX-101.PRE 13537
10 EXTRACTED XBRL INSTANCE DOCUMENT govx20221207_8k_htm.xml XML 4405
Mailing Address 1900 LAKE PARK DRIVE SUITE 380 SMYRNA GA 30080
Business Address 1900 LAKE PARK DRIVE SUITE 380 SMYRNA GA 30080 678-384-7220
GeoVax Labs, Inc. (Filer) CIK: 0000832489 (see all company filings)

IRS No.: 870455038 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39563 | Film No.: 221452355
SIC: 2834 Pharmaceutical Preparations